these studies demonstrated that monoclonal antibodies may be useful for short-term prophylaxis against prv-induced disease and that antibody directed against either prv glycoprotein glll or gp50 is sufficient to protect animals from prv-induced mortality .
C0003250
monoclonal antibodies
C0003241
antibody